Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
22.16
-0.32 (-1.42%)
Nov 4, 2024, 1:06 PM EST - Market open
KNSA Market Cap
KNSA has a market cap or net worth of $1.60 billion as of November 4, 2024. Its market cap has increased by 44.11% in one year.
Market Cap
1.60B
Enterprise Value
1.41B
1-Year Change
44.11%
Ranking
Category
Stock Price
$22.16
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $914.40M to $1.60B, an increase of 74.94%. That is a compound annual growth rate of 9.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 1.62B | 31.53% |
| Dec 29, 2023 | 1.23B | 18.44% |
| Dec 30, 2022 | 1.04B | 28.47% |
| Dec 31, 2021 | 810.80M | -32.60% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | 607.00M | -56.32% |
| Dec 31, 2018 | 1.39B | 51.96% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celldex Therapeutics | 1.70B |
| Viridian Therapeutics | 1.70B |
| Certara | 1.65B |
| Myriad Genetics | 1.63B |
| AtriCure | 1.63B |
| Ocular Therapeutix | 1.62B |
| Harrow | 1.62B |
| Syndax Pharmaceuticals | 1.62B |